told me that they would do something with the financial needs; but
nothing as far as I know has been done in any formal way. They
have no formal arrangement with Great Britain in the sense that
they have with Russia. And I think it's crazy. I haven't tried
to push them, because I felt there was nothing there to push,
that this arrangement of the White House was so crazy great, and although
-- if I'd been a Republican, maybe I would have tried, but as I'm not,
as I'm considered slightly suspect anyway being a Democrat, I
didn't try to push it.

Q:

Well, certainly it wouldn't be the time now as far, as Britain
is concerned.

Lasker:

Well, it wouldn't now. Now, certainly not, but I could
have done something about it last spring, but last spring in March,
you remember, there was the beginning of a in April.
It began to develop.

Q:

Has there been any new development in the area of arthritis?

Lasker:

There's a new drug developed by Winttorop called benoral,
which is said to be very useful. It's based on aspirin or
cylicitate, and it's said to be helpful to people who have difficulty
in just taking large amounts of aspirin. Then there's another
drug which Syntex has developed, which I haven't seen any
clinical trials, any results of any clinical trials in the United
States, which people close to syntex think is going to be important.
There's nothing that I know about that's outstanding.